Shui-Long Wang

Title: The Innovations of Shui-Long Wang

Introduction

Shui-Long Wang is a notable inventor based in San Diego, CA. He has made significant contributions to the field of diagnostics, particularly in the detection of therapeutic drugs and autoimmune responses. With a total of 3 patents, his work has the potential to greatly impact patient care and treatment optimization.

Latest Patents

One of his latest patents is focused on assays for the detection of anti-TNF drugs and autoantibodies. This invention provides methods for detecting and measuring the presence or level of anti-TNFα drug therapeutics and autoantibodies in a sample. It is particularly useful for optimizing therapy and monitoring patients receiving anti-TNFα drug therapeutics. Another significant patent addresses antibodies to microbiome, stress factors, and mast cell markers as diagnostic markers for irritable bowel syndrome (IBS). This invention aids in the diagnosis of IBS by determining whether a sample from an individual is an IBS sample or a healthy control sample using a statistical algorithm. This innovation offers an accurate diagnostic prediction of IBS and is beneficial for guiding treatment decisions.

Career Highlights

Shui-Long Wang has worked with prominent companies such as Nestec S.A. and Société des Produits Nestlé S.A. His experience in these organizations has contributed to his expertise in the field of diagnostics and therapeutics.

Collaborations

Throughout his career, Wang has collaborated with notable colleagues, including Sharat Singh and Nicholas Chi-Kwan Ling. These collaborations have likely enriched his research and development efforts.

Conclusion

Shui-Long Wang's contributions to the field of diagnostics through his innovative patents demonstrate his commitment to improving patient care. His work continues to influence the medical community and offers promising advancements in therapeutic monitoring and diagnosis.